Renalytix plc Deferred Tax Assets, in Process Research and Development
Renalytix plc (RNLXY) had Deferred Tax Assets, in Process Research and Development of $3.91 million as of 2024-06-30, per its 10-K filed 2024-09-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2024-09-30
- 2024-06-30: Deferred Tax Assets, in Process Research and Development $3.91M.
- 2023-06-30: Deferred Tax Assets, in Process Research and Development $2.83M.
- 2022-06-30: Deferred Tax Assets, in Process Research and Development $0.00.
| Period end | Deferred Tax Assets, in Process Research and Development |
|---|---|
| 2024-06-30 | $3.91M 10-K · filed 2024-09-30 |
| 2023-06-30 | $2.83M 10-K · filed 2024-09-30 |
| 2022-06-30 | $0.00 10-K · filed 2023-09-28 |